Annual CFF
$32.74 M
-$42.58 M-56.53%
31 December 2023
Summary:
Fortress Biotech annual cash flow from financing activities is currently $32.74 million, with the most recent change of -$42.58 million (-56.53%) on 31 December 2023. During the last 3 years, it has fallen by -$139.67 million (-81.01%). FBIO annual CFF is now -81.01% below its all-time high of $172.41 million, reached on 31 December 2020.FBIO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$2.71 M
-$11.55 M-81.00%
30 September 2024
Summary:
Fortress Biotech quarterly cash flow from financing activities is currently $2.71 million, with the most recent change of -$11.55 million (-81.00%) on 30 September 2024. Over the past year, it has increased by +$5.40 million (+200.97%). FBIO quarterly CFF is now -96.55% below its all-time high of $78.69 million, reached on 31 March 2021.FBIO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$88.45 M
+$5.40 M+6.50%
30 September 2024
Summary:
Fortress Biotech TTM cash flow from financing activities is currently $88.45 million, with the most recent change of +$5.40 million (+6.50%) on 30 September 2024. Over the past year, it has increased by +$80.71 million (+1042.95%). FBIO TTM CFF is now -61.26% below its all-time high of $228.35 million, reached on 31 March 2021.FBIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBIO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.5% | +201.0% | +1043.0% |
| 3 y3 years | -81.0% | -61.1% | -39.9% |
| 5 y5 years | -35.4% | -51.2% | -25.0% |
FBIO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -81.0% | at low | -94.6% | +108.9% | -40.6% | +1043.0% |
| 5 y | 5 years | -81.0% | at low | -96.5% | +108.9% | -61.3% | +1043.0% |
| alltime | all time | -81.0% | +422.4% | -96.5% | +108.9% | -61.3% | +725.5% |
Fortress Biotech Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.71 M(-81.0%) | $88.45 M(+6.5%) |
| June 2024 | - | $14.27 M(-48.8%) | $83.06 M(+116.2%) |
| Mar 2024 | - | $27.86 M(-36.1%) | $38.41 M(+17.3%) |
| Dec 2023 | $32.74 M(-56.5%) | $43.62 M(-1724.5%) | $32.74 M(+323.0%) |
| Sept 2023 | - | -$2.69 M(-91.2%) | $7.74 M(-45.4%) |
| June 2023 | - | -$30.38 M(-236.9%) | $14.17 M(-70.2%) |
| Mar 2023 | - | $22.19 M(+19.2%) | $47.54 M(-36.9%) |
| Dec 2022 | $75.32 M(-49.4%) | $18.62 M(+397.0%) | $75.32 M(-21.2%) |
| Sept 2022 | - | $3.75 M(+25.2%) | $95.64 M(-3.3%) |
| June 2022 | - | $2.99 M(-94.0%) | $98.86 M(-17.8%) |
| Mar 2022 | - | $49.96 M(+28.3%) | $120.27 M(-19.3%) |
| Dec 2021 | $148.99 M(-13.6%) | $38.94 M(+459.0%) | $148.99 M(+1.3%) |
| Sept 2021 | - | $6.97 M(-71.4%) | $147.07 M(-21.3%) |
| June 2021 | - | $24.39 M(-69.0%) | $186.93 M(-18.1%) |
| Mar 2021 | - | $78.69 M(+112.6%) | $228.35 M(+32.4%) |
| Dec 2020 | $172.41 M(+17.5%) | $37.02 M(-21.0%) | $172.41 M(+6.1%) |
| Sept 2020 | - | $46.83 M(-28.8%) | $162.55 M(+34.0%) |
| June 2020 | - | $65.81 M(+189.2%) | $121.27 M(+3.3%) |
| Mar 2020 | - | $22.75 M(-16.2%) | $117.35 M(-20.0%) |
| Dec 2019 | $146.71 M(+189.7%) | $27.16 M(+389.1%) | $146.71 M(+24.5%) |
| Sept 2019 | - | $5.55 M(-91.0%) | $117.87 M(-3.6%) |
| June 2019 | - | $61.89 M(+18.8%) | $122.27 M(+93.8%) |
| Mar 2019 | - | $52.11 M(-3180.0%) | $63.11 M(+24.6%) |
| Dec 2018 | $50.65 M(-66.3%) | -$1.69 M(-117.0%) | $50.65 M(-30.6%) |
| Sept 2018 | - | $9.96 M(+264.8%) | $73.00 M(-9.0%) |
| June 2018 | - | $2.73 M(-93.1%) | $80.18 M(-39.2%) |
| Mar 2018 | - | $39.66 M(+92.0%) | $131.88 M(-12.3%) |
| Dec 2017 | $150.38 M | $20.66 M(+20.5%) | $150.38 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $17.14 M(-68.5%) | $155.68 M(-0.5%) |
| June 2017 | - | $54.42 M(-6.4%) | $156.40 M(+51.1%) |
| Mar 2017 | - | $58.16 M(+124.1%) | $103.49 M(+141.2%) |
| Dec 2016 | $42.91 M(-29.6%) | $25.95 M(+45.3%) | $42.91 M(-25.3%) |
| Sept 2016 | - | $17.86 M(+1074.1%) | $57.41 M(+13.4%) |
| June 2016 | - | $1.52 M(-162.7%) | $50.62 M(+3.0%) |
| Mar 2016 | - | -$2.43 M(-106.0%) | $49.13 M(-19.4%) |
| Dec 2015 | $60.92 M(-699.9%) | $40.46 M(+265.6%) | $60.92 M(+145.4%) |
| Sept 2015 | - | $11.07 M(>+9900.0%) | $24.83 M(+101.5%) |
| June 2015 | - | $26.00 K(-99.7%) | $12.32 M(-0.8%) |
| Mar 2015 | - | $9.36 M(+114.1%) | $12.42 M(-222.3%) |
| Dec 2014 | -$10.15 M(-111.4%) | $4.37 M(-404.2%) | -$10.15 M(-28.2%) |
| Sept 2014 | - | -$1.44 M(-1249.6%) | -$14.14 M(-143.1%) |
| June 2014 | - | $125.00 K(-100.9%) | $32.82 M(-49.2%) |
| Mar 2014 | - | -$13.21 M(-3514.7%) | $64.59 M(-27.5%) |
| Dec 2013 | $89.16 M(+120.1%) | $387.00 K(-99.1%) | $89.16 M(+0.3%) |
| Sept 2013 | - | $45.52 M(+42.7%) | $88.87 M(+55.2%) |
| June 2013 | - | $31.90 M(+181.1%) | $57.28 M(+10.5%) |
| Mar 2013 | - | $11.35 M(>+9900.0%) | $51.86 M(+28.0%) |
| Dec 2012 | $40.51 M(+75.4%) | $105.00 K(-99.2%) | $40.51 M(-0.0%) |
| Sept 2012 | - | $13.93 M(-47.4%) | $40.52 M(+52.4%) |
| June 2012 | - | $26.48 M(>+9900.0%) | $26.59 M(+15.1%) |
| Mar 2012 | - | $0.00(-100.0%) | $23.09 M(0.0%) |
| Dec 2011 | $23.09 M(+21.3%) | $113.00 K(-1983.3%) | $23.09 M(+0.5%) |
| Sept 2011 | - | -$6000.00(-100.0%) | $22.98 M(-0.0%) |
| June 2011 | - | $22.99 M(>+9900.0%) | $22.99 M(>+9900.0%) |
| Mar 2011 | - | $0.00 | $0.00 |
| Dec 2010 | $19.04 M | - | - |
FAQ
- What is Fortress Biotech annual cash flow from financing activities?
- What is the all time high annual CFF for Fortress Biotech?
- What is Fortress Biotech annual CFF year-on-year change?
- What is Fortress Biotech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Fortress Biotech?
- What is Fortress Biotech quarterly CFF year-on-year change?
- What is Fortress Biotech TTM cash flow from financing activities?
- What is the all time high TTM CFF for Fortress Biotech?
- What is Fortress Biotech TTM CFF year-on-year change?
What is Fortress Biotech annual cash flow from financing activities?
The current annual CFF of FBIO is $32.74 M
What is the all time high annual CFF for Fortress Biotech?
Fortress Biotech all-time high annual cash flow from financing activities is $172.41 M
What is Fortress Biotech annual CFF year-on-year change?
Over the past year, FBIO annual cash flow from financing activities has changed by -$42.58 M (-56.53%)
What is Fortress Biotech quarterly cash flow from financing activities?
The current quarterly CFF of FBIO is $2.71 M
What is the all time high quarterly CFF for Fortress Biotech?
Fortress Biotech all-time high quarterly cash flow from financing activities is $78.69 M
What is Fortress Biotech quarterly CFF year-on-year change?
Over the past year, FBIO quarterly cash flow from financing activities has changed by +$5.40 M (+200.97%)
What is Fortress Biotech TTM cash flow from financing activities?
The current TTM CFF of FBIO is $88.45 M
What is the all time high TTM CFF for Fortress Biotech?
Fortress Biotech all-time high TTM cash flow from financing activities is $228.35 M
What is Fortress Biotech TTM CFF year-on-year change?
Over the past year, FBIO TTM cash flow from financing activities has changed by +$80.71 M (+1042.95%)